Familial clustering of endometrial cancer in a well-defined population

Gynecologic Oncology

Volumn 122, Issue 1, 2011, Pages 75-78

  Seger, Hillary M Moore ^a   Soisson, Andrew P ^a,b   Dodson, Mark K ^a,c   Rowe, Kerry G ^c   Cannon Albright, Lisa A ^a,d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c INTERMOUNTAIN HEALTHCARE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Endometrial cancer; Epidemiology; Genetics

Indexed keywords

ARTICLE; BODY MASS; CANCER RISK; ENDOMETRIUM CANCER; FEMALE; HEREDITY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR PHYLOGENY; OBESITY; PEDIGREE; PRIORITY JOURNAL; RELATIVE; RISK FACTOR;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; ENDOMETRIAL NEOPLASMS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; PEDIGREE; REGISTRIES; RISK FACTORS; UTAH;

EID: 79957706021     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.03.009     Document Type: Article

References (31)

1. American Cancer Society, Cancer Facts & Figures 2008, American Cancer Society: Atlanta.
2. Daniel C, Chung M, Anil K, Rustgi MD. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med 2003;138(7):560-70.
3. Kataoka N, Cai Q, Xu W, Xiang Y, Cai H, Zheng W, et al. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene. Cancer 2007;109(7):1296-302. (Pubitemid 46466556)
4. Ueda M, Terai Y, Kanda K, Kanemura M, Takehara M, Yamaguchi H, et al. Germline polymorphism of p53 codon 72 in gynecological cancer. Gynecol Oncol 2006;100(1):173-8. (Pubitemid 41815069)
5. Xu L, Hu Y, Chen B, Tang W, Han X, Yu H, et al. Mitochondrial polymorphisms as risk factors for endometrial cancer in southwest China. Int J Gynecol Cancer 2006;16(4):1661-7. (Pubitemid 44060395)
6. Xu W, Shrubsole M, Xiang Y, Cai Q, Zhao G, Ruan Z, et al. Dietary folate intake, MTHFR genetic polymorphisms, and the risk of endometrial cancer among Chinese women. Cancer Epidemiol Biomark Prev 2007;16(2):281-7.
7. Han J, Hankinson S, De Vivo I. Polymorphisms in O6-methylguanine DNA methyltransferase and endometrial cancer risk. Carcinogenesis 2006;27(11):2281-5. (Pubitemid 44644817)
8. McGrath M, Lee I, Hankinson S, Kraft P, Hunter D, Buring J, et al. Androgen receptor polymorphisms and endometrial cancer risk. Int J Cancer 2006;118(5):1261-8. (Pubitemid 43185615)
9. Paynter R, Hankinson S, Colditz G, Kraft P, Hunter D, De Vivo I. CYP19 (aromatase) haplotypes and endometrial cancer risk. Int J Cancer 2005;116(2):267-74. (Pubitemid 40967264)
10. Szyllo K, Smolarz B, Romanowicz-Makowska H, Kulig A. The polymorphisms of the CYP17 and CYP19 genes in endometrial cancer patients. Pol J Pathol 2006;57(1):35-40. (Pubitemid 43886167)
11. Haiman C, Hankinson S, Colditz G, Hunter D, De Vivo I. A polymorphism in CYP17 and endometrial cancer risk. Cancer Res 2001;61(10):3955-60. (Pubitemid 32720957)
12. Einarsdottir K, Humphreys K, Bonnard C, Li Y, Li Y, Chia K, et al. Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk. Hum Mol Genet 2007;16(2):154-64.
13. Walsh C, Miller C, Karlan B, Koeffler H. Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk. Gynecol Oncol 2007;104(3):660-4.
14. Tao M, Cai Q, Xu WH, Kataoka N, Wen W, Zheng W, et al. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and endometrial cancer risk in Chinese women. Cancer Epidemiol Biomark Prev 2006;15(12):2570-3. (Pubitemid 46048324)
15. Dossus L, Canzian F, Kaaks R, Boumertit A, Weiderpass E. No Association between progesterone receptor gene +331G/A polymorphism and endometrial cancer. Cancer Epidemiol Biomark Prev 2006;15(7):1415-6. (Pubitemid 44125304)
16. Beiner M, Finch A, Rosen B, Lubinski J, Moller P, Ghadirian P, et al. The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study. Gynecol Oncol 2007;104(1):7-10. (Pubitemid 46054134)
17. Black D, Bogomolniy F, Robson M, Offit K, Barakat R, Boyd J. Evaluation of germline PTEN mutations in endometrial cancer patients. Gynecol Oncol 2005;96(1):21-4. (Pubitemid 39612412)
18. Hayes M, Wang H, Espinal-Witter R, Douglas W, Solomon GJ, Baker SJ, et al. PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia. Clin Cancer Res 2006;15(12(20 Pt 1)):5932-5.
19. Kitao K, Yoshida S, Kennedy S, Takemura N, Sugimoto M, Deguchi M, et al. Epidermal growth factor receptor and human epidermal growth factor receptor 2 gene polymorphisms in endometrial cancer in a Japanese population. Reprod Sci 2007;14(4):349-57. (Pubitemid 351168808)
20. Konac E, Onen H, Metindir J, Alp E, Biri A, Ekmekci A. Lack of association between -460C/T and 936C/T of the vascular endothelial growth factor and angiopoietin-2 exon 4G/A polymorphisms and ovarian, cervical, and endometrial cancers. DNA Cell Biol 2007;26(7):453-63. (Pubitemid 47105607)
21. Koornstra J, Mourits MJ, Sijmons RH, Leliveld AM, Hollema H, Kleibeuker JH. Management of extracolonic tumors in patientswith Lynch syndrome. Lancet Oncol 2009;10(4):400-8.
22. Chung C, RustgiA. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med 2003;138(7):560-70.
23. Skolnick M. The Utah genealogical database: a resource for genetic epidemiology. In: Cairns J, Lyon JL, Skolnick M, editors. Cancer Incidence in Defined Populations. New York: Cold Spring Harbor Laboratory Press; 1980. p. 285-97.
24. McLellan T, Jorde LB, Skolnick MH. Genetic distances between the Utah Mormons and related populations. Am J Hum Genet 1984;36:836-7.
25. Jorde L. Inbreeding in the Utah Mormons: an evaluation of estimates based on pedigrees, isonomy, and migration matrices. Ann Hum Genet 1989;53:339-55. (Pubitemid 19282107)
26. Weires M, Tausch B, Haug PJ, Edwards CQ, Wetter T, Cannon-Albright LA. Familiality of diabetes mellitus. Exp Clin Endocrinol Diabetes 2007;115:1-7.
27. Horne BD, C.N., Muhlestein JB, Cannon-Albright LA. Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database. Am Heart J 2006;152:305-11. (Pubitemid 44109831)
28. Maul J, Burt RW, Cannon-Albright LA. A familial component to human rectal cancer, independent of colon cancer risk. Clin Gastroenterol Hepatol 2007;5:1080-4.
29. Miki Y, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266(5182):66-71. (Pubitemid 24345325)
30. Tavtigian S, Simard J, Teng DHF, Abtin V, Baumgard M, Beck A, et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 2001;27:172-80. (Pubitemid 32157444)
31. Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gris, NA., Ding, W. et al., Analysis of the p16 (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility loci. Nat Genet. 8: p. 22-26.